DAXX

Death domain-associated protein 6 · Q9UER7 · DAXX on Sugi Atlas →

0 patent compounds predicted against DAXX, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to DAXX by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Pembrolizumab Plus Enfortumab Vedotin in Collecting Duct and Renal Medullary Carcinoma PHASE2RECRUITING
A Phase Ib/II Clinical Study Evaluating the Safety and Efficacy of Tislelizumab in Combination With Golidocitinib and Selinexor for the Treatment of R/R NKTCL PHASE1/PHASE2RECRUITING
Evaluation of the Possible Safety and Efficacy of Dapagliflozin in the Prophylaxis of Doxorubicin-Induced Cardiotoxicity PHASE2RECRUITING
Phase II Study of Vandetanib in Individuals With Kidney Cancer PHASE2COMPLETED
Effect of Deferoxamine on Wound Healing Rate in Patients With Diabetes Foot Ulcers PHASE2NOT_YET_RECRUITING
Clinical Study of EBV-LMP1 Targeted DNAzyme to Treat Nasopharyngeal Carcinoma PHASE1/PHASE2COMPLETED
Study Evaluating Toxicity & Efficacy of Lenalidomide(Revlimid®)in Chemotherapy-Naïve AIPC Patients PHASE2COMPLETED
Phase I Study of Gene Induction Mediated by Sequential Decitabine/Depsipeptide Infusion With or Without Concurrent Celecoxib in Subjects With Pulmonary and Pleural Malignancies PHASE1COMPLETED
A Phase I Study Of Thymoglobulin In Patients With Relapsed Or Refractory Multiple Myeloma PHASE1COMPLETED
Study on the Safety and Tolerability of PD-1 Knockout Tumor-infiltrating T Cells (TILs) in the Treatment of Advanced Colorectal Cancer PHASE1RECRUITING
Genetic Determinants of Sudden Cardiac Death nanCOMPLETED
Tecfidera Diffusion Tensor Imaging nanCOMPLETED
PHF19 Gene Expression and EZH2 Gene Deletion in Acute Myeloid Leukemia nanUNKNOWN
Autophagy in Systemic Lupus Erythematosus nanUNKNOWN
Genetics of Endocrine Tumours - Familial Isolated Pituitary Adenoma - FIPA nanRECRUITING
PCD New Gene Discovery nanCOMPLETED
New Signaling Pathway Targeting Systemic Lupus Erythematosus nanUNKNOWN
Circulating Markers for Ischemic Heart Disease nanRECRUITING
Identification of Genes and Pathogenesis Involved in Familial Thoracic Aortic Aneurysm nanCOMPLETED
Apoptosis Markers in Aggressive Periodontitis nanCOMPLETED
Molecular Associations With Reproductive Failure nanCOMPLETED
Adipocytokines in Endometrial Cancer nanCOMPLETED
IVF Outcome in Polycystic Ovary Syndrome Patients nanUNKNOWN
Genetic Markers and Biomarkers in Patients With Intellectual Disabilities of Genetic Origin nanRECRUITING
Depressed AIRE Gene Expression Causes Immune Cell Dysfunction & Autoimmunity in Down Syndrome nanCOMPLETED
Germline Alterations of Tumor Susceptibility Genes in New York Cancer Patients nanACTIVE_NOT_RECRUITING
Clinical Study of 68Ga-DOTA-BLP PET Imaging in Noninvasive Diagnosis of Malignant Tumors nanNOT_YET_RECRUITING
Pathogenetic Basis of Aortopathy and Aortic Valve Disease nanACTIVE_NOT_RECRUITING
TIPE2 Associated With Kidney Transplant nanSUSPENDED
ADAR1 Expression Level in Rectal Cancer nanRECRUITING

Related proteins — ESM-2 sequence neighbours (a DAXX binder may also engage these)

ProteinNameSimilarity
O18805 1.000 O18805 →
O35613 1.000 O35613 →
Q5TJE1 1.000 Q5TJE1 →
Q8VIB2 1.000 Q8VIB2 →
A6QLA6 0.994 A6QLA6 →
Q76LL6 0.991 Q76LL6 →
Q76N89 0.991 Q76N89 →
Q8R409 0.991 Q8R409 →
Q6PCQ0 0.990 Q6PCQ0 →
Q3UJB9 0.990 Q3UJB9 →
Q9CYA6 0.989 Q9CYA6 →
Q9BQK8 0.989 Q9BQK8 →
A0JMK9 0.989 A0JMK9 →
Q0X0C4 0.989 Q0X0C4 →
Q9JL04 0.989 Q9JL04 →
B1H224 0.989 B1H224 →
Q9Y6A5 0.988 Q9Y6A5 →
O70405 0.988 O70405 →
Q80TG1 0.988 Q80TG1 →
Q8VDP4 0.988 Q8VDP4 →
Q922B9 0.988 Q922B9 →
NFRKB Nuclear factor related to kappa-B-binding protein 0.988 landscape →
E1BE02 0.988 E1BE02 →
Q9QXY4 0.988 Q9QXY4 →
Q3TES0 0.988 Q3TES0 →
Q07G43 0.988 Q07G43 →
MSL1 Male-specific lethal 1 homolog 0.987 landscape →
Q08E13 0.987 Q08E13 →
O94992 0.987 O94992 →
Q6P1I6 0.987 Q6P1I6 →